HA NGUYEN: Open Payments
NPI 1790107217 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$86 in 4 payments from 4 companies in 2025. Trend: 2023 $77 · 2024 $86 · 2025 $86
Food & beverage: $86
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Stryker Corporation | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Sandoz Inc. | 1 | $14 |
Products named: KESIMPTA, PRIME SERIES, BENLYSTA, Tyruko.
Industry payments across TX — which companies pay providers there.
